New blood test could predict kidney transplant rejection before it happens

NCT ID NCT04727788

Ongoing Diagnosis Sponsor: Verici Dx Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a blood test that looks at gene activity to predict the risk of kidney transplant rejection. Researchers will follow 550 kidney transplant recipients to see if the test can identify those at risk for early rejection or long-term damage. The goal is to help doctors intervene sooner and improve transplant outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this blood test could help doctors identify kidney transplant patients at high risk for rejection early, allowing for personalized treatment.
What could go wrong: This is an observational study, not a treatment trial. The test may not be accurate enough for widespread use, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT REJECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

transplant rejection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KIDNEY TRANSPLANT REJECTION

Contacts and locations

Locations

Bologna University

Bologna, Italy
Brescia University

Brescia, Italy
CHU Grenoble Alpes Health Center

Grenoble, France
Cleveland Clinic

Cleveland, Ohio, 44195, United States
Henry Ford

Detroit, Michigan, 48202, United States
Northwestern University

Evanston, Illinois, 60611, United States
University Hospital Vall d'Hebron, Barcelona

Barcelona, Spain
University of Illinois at Chicago

Chicago, Illinois, 60612, United States
University of Maryland

Baltimore, Maryland, 21201, United States
University of Nebraska Medical Center

Omaha, Nebraska, 68198, United States
University of Pittsburgh

Pittsburgh, Pennsylvania, 15261, United States
University of Washington

Seattle, Washington, 98195, United States
Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.